These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22816505)

  • 1. A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.
    Tsai TF; Chiu HY; Song M; Chan D
    Br J Dermatol; 2013 Feb; 168(2):444-6. PubMed ID: 22816505
    [No Abstract]   [Full Text] [Related]  

  • 2. Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxis.
    Errichetti E; Piccirillo A
    Eur J Dermatol; 2014; 24(4):508-9. PubMed ID: 25120233
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactivation of latent tuberculosis in a Crohn's patient after TB prophylaxis treated with adalimumab.
    Caldera F; Grimes I; Soni A
    Am J Gastroenterol; 2013 Jul; 108(7):1181-2. PubMed ID: 23821003
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment.
    Sánchez-Moya AI; Daudén E
    Arch Dermatol; 2012 Nov; 148(11):1332-3. PubMed ID: 23165852
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
    Tsai TF; Ho V; Song M; Szapary P; Kato T; Wasfi Y; Li S; Shen YK; Leonardi C;
    Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Is it safe?' Safety is a process, not a question.
    Shear NH
    Br J Dermatol; 2012 Nov; 167(5):968-9. PubMed ID: 23106352
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of secukinumab in psoriasis patients with latent tuberculosis infection.
    Machado Á; Abreu M; Torres T
    Eur J Dermatol; 2020 Dec; 30(6):740-741. PubMed ID: 33237033
    [No Abstract]   [Full Text] [Related]  

  • 8. New challenges for the pulmonologist in the diagnosis of latent tuberculosis infection: biological treatment and pulmonary tuberculosis.
    Hernández González F; Sanz Herrero F; Lloret Pérez T
    Arch Bronconeumol; 2011 Jul; 47(7):375. PubMed ID: 21440975
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious?
    Sánchez-Moya AI; Dauden E
    Int J Dermatol; 2014 Mar; 53(3):e211-2. PubMed ID: 23786208
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.
    Korta DZ; Ochieng P; Fishman D; Katz SE
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
    Currie GP; Emmanuel FX; Ford D; Devereux G
    J Infect; 2005 Dec; 51(5):e305-8. PubMed ID: 16321645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.
    Koskinas J; Tampaki M; Doumba PP; Rallis E
    Br J Dermatol; 2013 Mar; 168(3):679-80. PubMed ID: 23121260
    [No Abstract]   [Full Text] [Related]  

  • 13. No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.
    Mrowietz U; Riedl E; Winkler S; Xu W; Patel H; Agada N; Lebwohl MG
    J Am Acad Dermatol; 2020 Nov; 83(5):1436-1439. PubMed ID: 32526319
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy.
    Agudo B; Díaz G; González-Lama Y
    J Crohns Colitis; 2016 Dec; 10(12):1453-1454. PubMed ID: 27215554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
    Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
    Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprophylaxis with isoniazid in liver transplant recipients.
    Fábrega E; Sampedro B; Cabezas J; Casafont F; Mieses MÁ; Moraleja I; Crespo J; Pons-Romero F
    Liver Transpl; 2012 Sep; 18(9):1110-7. PubMed ID: 22645064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases.
    de Souza A; Ali-Shaw T; Reddy SM; Fiorentino D; Strober BE
    Br J Dermatol; 2013 Jan; 168(1):210-2. PubMed ID: 23278559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual presentation of tuberculosis in an infliximab-treated patient--which is the correct TB screening before starting a biologic?
    Gori A; Fabroni C; Prignano F; Lotti T
    Dermatol Ther; 2010; 23 Suppl 1():S1-3. PubMed ID: 20136915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.
    Baghban A; Azar MM; Bernardo RM; Malinis M
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27852682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis.
    Aslam A; Green RL; Motta L; Ghrew M; Griffiths CE; Warren RB
    Br J Dermatol; 2013 Feb; 168(2):446-7. PubMed ID: 22816532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.